Natural Beauty Bio-Technology (0157) Fundamentals 2026 — P/E 87.7x, Revenue Analysis | SniperIQ
Natural Beauty Bio-Technology (0157) is a HK-listed Consumer Defensive company in Household & Personal Products with a market capitalization of HK$931M, trading at HK$0.47 on the HKSE. This SniperIQ fundamentals page covers Natural Beauty Bio-Technology's valuation (P/E 87.7x, P/B 2.0x), profitability (net margin 2.0%), revenue (HK$539M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Natural Beauty Bio-Technology's market cap?
Natural Beauty Bio-Technology (0157) has a market capitalization of approximately HK$931M, trading at HK$0.47 on the HKSE. Market cap moves with the live share price.
What is Natural Beauty Bio-Technology's P/E ratio?
Natural Beauty Bio-Technology's trailing twelve-month P/E ratio is 87.7x, with a price-to-book (P/B) of 2.0x. Valuation multiples are best compared with Consumer Defensive sector peers rather than read in isolation.
How profitable is Natural Beauty Bio-Technology?
Natural Beauty Bio-Technology runs a net profit margin of 2.0%, a gross margin of 54.4%, and an operating margin of 4.3%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Natural Beauty Bio-Technology generate?
Natural Beauty Bio-Technology reported revenue of HK$539M for fiscal year 2025, with net income of HK
Does Natural Beauty Bio-Technology pay a dividend?
Natural Beauty Bio-Technology does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Natural Beauty Bio-Technology financially healthy?
Natural Beauty Bio-Technology carries a debt-to-equity ratio of 0.67x and a current ratio of 1.11x, with a market beta of -0.12. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Natural Beauty Bio-Technology a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Natural Beauty Bio-Technology (0157) the key facts are: market cap HK$931M, P/E 87.7x, revenue HK$539M, 52-week range 0.39-0.63. Weigh valuation, profitability, growth, and balance-sheet strength against Consumer Defensive peers and form your own view.
Track Natural Beauty Bio-Technology's full fundamentals live
Get Natural Beauty Bio-Technology's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.